摘要
目的：探讨联用中药心通口服液与西药硝酸异山梨醇酯治疗冠状动脉粥样硬化性心脏病（冠心病）心绞痛的疗效。方法：将６８ 例冠心病心绞痛患者随机分为２ 组。治疗组（３６ 例）用中药心通口服液与西药硝酸异山梨醇酯治疗，对照组（３２ 例）单用硝酸异山梨醇酯治疗；药物剂量：心通口服液１０ ｍ ｌ，硝酸异山梨醇酯１０ ｍ ｇ，均为每日３ 次口服，３ 周为１ 个疗程。结果：治疗组及对照组临床症状改善总有效率分别为８８９％ 及６１８％ ，有显著性差异（ Ｐ＜ ００５）；心电图改善总有效率分别为８０６％ 及５３１％ ，亦有显著性差异（ Ｐ＜ ００５）。结论：心通口服液与硝酸异山梨醇酯合用治疗冠心病心绞痛对心绞痛症状及心电图的心肌缺血改善均优于单用硝酸异山梨醇酯。
Objective:To investigate the curative effects of Xintong Oral Liquid (心通口服液) and isosorbide on angina pectoris (AP) of coronary atherosclerosis heart disease (CAHD).Methods:68 patients were randomly divided into two groups.The treatment group ( n =36) was treated with Xintong Oral Liquid 10 ml three times a day combined with isosorbide 10 mg three times a day otherwise the control group ( n =32) treated with isosorbide 10 mg alone three times a day for 3 weeks as a therapeutic course.Results:The total effective rates of clinically symptomatic improvements in treatment group and control group were 88 9% and 61 8% respectively and had significant difference ( P <0 05) meanwhile the total effective rates of electrocardiogram improvements were 80 6% and 53 1% and had significant difference too ( P <0 05),Conclusions:The curative effects of Xintong Oral Liquid combined with isosorbide on improvements of symptom of angina pectoris and myocardiac ischemia of electrocardiogram of CAHD are superior to those of isosorbide alone.
出处
《中国中西医结合急救杂志》
CAS
1999年第8期365-366,共2页
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care
关键词
心绞痛
心通口服液
硝酸异山梨醇酯
冠心病
coronary atherosclerosis heart disease
angina pectoris
Xintong Oral Liquid
isosorbide CLC number:R541.4
Document code:A
Artical ID:10089691(1999)08036502
